glp-1 announcement Virta Health Cuts Use for Weight Loss Over 50% While Driving Significant and Sustained Outcomes, Delivering Major Cost Savings for Payers GLP-1 pricing is changing. Here’s

Additionally, those suffering from severe gastrointestinal issues, such as gastroparesis, may not be ideal candidates since the medication can slow gastric emptying

FDA-approved weight management medications beyond GLP-1 agonists include: Phentermine-topiramate (Qsymia): Combination sympathomimetic and anticonvulsant showing 8-10% weight loss in clinical trials

Chao AM, Wadden TA, Walsh OA, et al

Compounded formulations are made in licensed 503A pharmacies under USP standards

[DOI] [PMC free article] [PubMed] [Google Scholar] 64.Cao Y, Tong Q

Generalizability is limited to patients in health systems contributing to Cosmos.